Devalingam Mahalingam, MD, PhD

Devalingam Mahalingam
Medical Oncology
Translational Research and Drug Development
Medical School:
National University of Ireland, Galway (NUIG), Ireland
University College Hospital, Galway, Ireland
Letterkeney General Hospital, Ireland
James Connolly Memorial Hospital, Dublin, Ireland
University College Hospital, Galway, Ireland
Institute of Drug Development, San Antonio, TX
Board Certifications:

Dr. Mahalingam is a faculty member in the division of hematology/oncology. He completed his internal medicine training and medical oncology fellowship in Ireland, during which time he also concurrently received his Ph.D. research in 2008 with a focus on drug development. He then completed the Advanced Fellowship Program at the Institute for Drug Development at CTRC before his appointment as assistant professor of medicine at the CTRC. His career is dedicated to clinical and laboratory research in gastrointestinal (GI) and genitourinary (GU) cancers. Among his clinical research interests is a focus on hepatocellular cancer in the GI clinic. His groundbreaking research has been presented in many scientific seminars and large international meetings.